33500-88-8

Basic information

• Product Name: Benzene, 1-bromo-2-methoxy-4,5-dimethyl-
• Synonyms: 2-Bromo-4,5-dimethylanisol;2-Brom-4,5-dimethyl-anisol;2-bromo-4,5-dimethyl-anisole;Benzene,1-bromo-2-methoxy-4,5-dimethyl;5-Brom-4-methoxy-o-xylol
• CAS NO: 33500-88-8
• Molecular Formula: C9H11BrO
• Molecular Weight: 215.09
• Mol File: 33500-88-8.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: Benzene, 1-bromo-2-methoxy-4,5-dimethyl-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzene, 1-bromo-2-methoxy-4,5-dimethyl-(33500-88-8)
• EPA Substance Registry System: Benzene, 1-bromo-2-methoxy-4,5-dimethyl-(33500-88-8)

Safety Data

• Hazardous Substances Data: 33500-88-8(Hazardous Substances Data)

Upstream product

• 95-65-8 3,4-Dimethylphenol 
• 22802-39-7 2-bromo-4,5-dimethylphenol 
• 77-78-1 dimethyl sulfate 
• 4685-47-6 3,4-dimethylanisole 

Downstream Products

• 1207065-35-7 1-bromo-4,5-bis(bromomethyl)-2-methoxybenzene 
• 1134082-52-2 2-(2-Methoxy-4,5-dimethylphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 
• 108123-09-7 (2-Methoxy-4,6-dimethyl-phenyl)-phenyl-sulfon 
• 2493-70-1 Phenyl-<2-hydroxy-4,5-dimethylphenyl>sulfon 
• 138042-05-4 N,N-diethyl-6-methoxy-3,4-dimethyl-2-trimethylsilylbenzamide 
• 138042-08-7 4,5-dihydro-2-(2'-methoxy-4',5'-dimethylphenyl)-4,4-dimethyloxazole 
• 138042-07-6 N-(2'-hydroxy-1',1'-dimethylethyl)-2-methoxy-4,5-dimethylbenzamide 
• 138042-04-3 1-(2-methoxy-4,5-dimethylphenyl)-2-methylbutan-1-one 
• 159847-56-0 N,N-dimethyl-(2-methoxy-4,5-dimethyl-6-prop-2'-enyl)benzamide 
• 159847-58-2 N-methyl-(2-methoxy-4,5-dimethyl)benzamide 
• 108125-23-1 (2-Methoxy-4,5-dimethyl-phenyl)-phenyl-sulfid 
• 159847-55-9 N,N-dimethyl-2-methoxy-4,5-dimethylbenzamide 
• 82544-94-3 N,N-diethyl-(2-methoxy-4,5-dimethyl)benzamide 
• 138042-06-5 2-methoxy-4,5-dimethylbenzanilide 

Relevant articles and documents

As neuroprotective agents of pharmaceutical compounds

The invention discloses a medicinal compound as a neuroprotective agent. The medicinal compound is a neuronal nitric oxide synthase-postsynaptic density protein 95 (nNOS-PSD95) decoupling agent. The medicinal compound is a benzene ring derivative shown in the general formula (I) or its pharmaceutically acceptable salt. The invention further discloses a preparation method of the medicinal compound and a use of the medicinal compound in prevention and treatment on neuronal damage influence-caused diseases.

Synthesis of the conformationally constrained tyrosine analogues, (R)- and (S)-5-hydroxy-2-aminoindan-2-carboxylic acids

(Chemical Equation Presented) The conformationally constrained tyrosine analogues, (R)- and (S)-5-hydroxy-2-aminoindan-2-carboxylic acids, were prepared by chromatographic separation of diastereomeric dipeptide derivatives formed from N-Boc-L-phenylalanin